AMGN

MKT CAP:$178B

Amgen Inc

Market Cap

$178B

Healthcare·Drug Manufacturers - General·🇺🇸 United States·NASDAQ

Healthcare·Drug Mfg.·🇺🇸·NASDAQ

Stock Price

$345.73+$22.78 (+7.05%)

Jun 8, 2026

52W High $385.2552W Low $264.49

Company Details

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the tr...

CEO

—

IPO Date

Jun 17, 1983

Website

www.amgen.com

Key Metrics TTM

Revenue

$37.2B

+9.1% YoY

Net Income

$7.8B

EPS (Diluted)

Free Cash Flow

$8.6B

Revenue / Share

$68.45

Gross Margin

71.5%

Operating Margin

31.6%

Net Margin

20.9%

FCF Margin

23.1%

P/S

4.8x

P/E

22.8x

Earnings Reports

Q2 2026

Aug 4, 2026

PENDING

Q1 2026

Apr 30, 2026

$8.6B+5.8%

FY 2025

Feb 13, 2026

$36.7B+9.9%

Q4 2025

Feb 13, 2026

$9.9B+8.9%

Q3 2025

Nov 5, 2025

$9.6B+12.4%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee